CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $23.07M, above the global median of $16.24M
- FinancialsAltman Z-Score 4.15: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
5.39%Above 5Y avg (4.64%)
Annual Rate
TWD 3.00Paid annual
Payout Ratio
89.0%High
Payback Period
18.6 yr
Last Ex-Dividend
Jun 24, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
14.84BTWD465.60M · vs all stocks (USD)
Trailing P/E
16.23xRevenue (TTM)
7.84BTWD246.09M · vs all stocks (USD)
Profit Margin
11.43%Beta
0.0910xvs all stocks
52-Week Change
-0.36%vs all stocks
Market Capitalization
14.84BTWD465.60M · vs all stocks (USD)
Enterprise Value
13.61BTWD427.22M · vs all stocks (USD)
Trailing P/E
16.23xPEG Ratio
-0.5872xPrice to Sales (TTM)
1.86xPrice to Book (MRQ)
1.87xEnterprise to Revenue
1.74xEnterprise to EBITDA
9.74xGross Margin
44.23%Profit Margin
11.43%Operating Margin
14.59%Return on Assets (TTM)
5.57%Return on Equity (TTM)
11.45%Revenue (TTM)
7.84BTWD246.09M · vs all stocks (USD)
Revenue per Share (TTM)
29.44TWDUpdated Aug 20, 2026Quarterly Revenue Growth
-9.20%Gross Profit (TTM)
3.42BTWD107.27M · vs all stocks (USD)
EBITDA (TTM)
1.48BTWD46.50M · vs all stocks (USD)
Net Income (TTM)
896.24MTWD28.13M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
112.50%Operating Cash Flow (TTM)
1.39BTWD43.49M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
735.06MTWD23.07M · vs all stocks (USD)
Trailing Annual Dividend Rate
3.00TWDUpdated Aug 20, 2026Trailing Annual Dividend Yield
5.39%vs all stocks
5-Year Average Dividend Yield
4.64%vs all stocks
Payout Ratio
89.02%Minority Interest (Equity)
815.89MTWDFY2025 · Dec 31, 2025Revenue
8.38BTWDFY2025 · Dec 31, 2025Cost of Goods Sold
4.73BTWDFY2025 · Dec 31, 2025Gross Profit
3.65BTWDFY2025 · Dec 31, 2025Operating Income
1.32BTWD41.46M · vs all stocks (USD)
Pre-tax Income
1.30BTWDFY2025 · Dec 31, 2025Income Tax Expense
355.69MTWDFY2025 · Dec 31, 2025Net Income
948.41MTWDFY2025 · Dec 31, 2025EBIT
1.32BTWDFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.62BTWDFY2025 · Dec 31, 2025Research & Development
392.41MTWDFY2025 · Dec 31, 2025Selling, General & Administrative
1.93BTWDFY2025 · Dec 31, 2025Non-operating Interest Income
39.43MTWDFY2025 · Dec 31, 2025Non-operating Interest Expense
18.96MTWDFY2025 · Dec 31, 2025Minority Interests (P&L)
-67.59MTWDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TWDFY2025 · Dec 31, 2025Operating Cash Flow
1.45BTWDFY2025 · Dec 31, 2025Free Cash Flow
950.16MTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.20BTWDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
1.30BTWDFY2025 · Dec 31, 2025Stock-based Compensation
8.30MTWDFY2025 · Dec 31, 2025Other Non-cash Items
48.70MTWDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-128.95MTWDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
216.22MTWDFY2025 · Dec 31, 2025Capital Expenditures
-498.21MTWDFY2025 · Dec 31, 2025Net Intangibles (CF)
-6.33MTWDFY2025 · Dec 31, 2025Net Acquisitions
-75.04MTWDFY2025 · Dec 31, 2025Purchase of Investments
-2.03BTWDFY2025 · Dec 31, 2025Sale of Investments
1.17BTWDFY2025 · Dec 31, 2025Other Investing Activity
-96.92MTWDFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.53BTWDFY2025 · Dec 31, 2025Long-term Debt Issuance
933.58MTWDFY2025 · Dec 31, 2025Long-term Debt Payments
-1.41BTWDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-390.04MTWDFY2025 · Dec 31, 2025Common Dividends Paid
-860.60MTWDFY2025 · Dec 31, 2025Other Financing Charges
205.77MTWDFY2025 · Dec 31, 2025Net Financing Cash Flow
-1.52BTWDFY2025 · Dec 31, 2025Shares Outstanding
266.37MSharesUpdated Aug 20, 2026Float Shares
157.32MSharesUpdated Aug 20, 2026% Held by Insiders
34.55%vs all stocks
% Held by Institutions
5.27%vs all stocks
Total Cash (MRQ)
2.97BTWD93.05M · vs all stocks (USD)
Total Cash per Share (MRQ)
11.13TWDUpdated Aug 20, 2026Total Debt (MRQ)
1.30BTWD40.70M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1511xCurrent Ratio (MRQ)
2.50xBook Value per Share (MRQ)
29.25TWDUpdated Aug 20, 2026Total Assets
12.61BTWD395.81M · vs all stocks (USD)
Total Current Assets
7.01BTWDFY2025 · Dec 31, 2025Total Liabilities
3.64BTWDFY2025 · Dec 31, 2025Total Non-current Assets
5.60BTWDFY2025 · Dec 31, 2025Total Non-current Liabilities
1.62BTWDFY2025 · Dec 31, 2025Total Current Liabilities
2.02BTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.20BTWDFY2025 · Dec 31, 2025Other Short-term Investments
1.25BTWDFY2025 · Dec 31, 2025Accounts Receivable
1.51BTWDFY2025 · Dec 31, 2025Inventory
2.60BTWDFY2025 · Dec 31, 2025Accounts Payable
584.22MTWDFY2025 · Dec 31, 2025Short-term Debt
310.37MTWDFY2025 · Dec 31, 2025Other Current Liabilities
53.14MTWDFY2025 · Dec 31, 2025Long-term Debt
874.93MTWDFY2025 · Dec 31, 2025Other Non-current Liabilities
2.92MTWDFY2025 · Dec 31, 2025Common Stock (Book)
2.66BTWDFY2025 · Dec 31, 2025Retained Earnings
2.00BTWDFY2025 · Dec 31, 2025Total Shareholders' Equity
8.97BTWD281.64M · vs all stocks (USD)
Treasury Stock
1.44MTWDFY2025 · Dec 31, 202552-Week Low
51.90TWDUpdated Aug 20, 202652-Week High
59.60TWDUpdated Aug 20, 202652-Week Change
-0.36%vs all stocks
Beta
0.0910xvs all stocks
50-Day MA
54.75TWDUpdated Aug 20, 2026200-Day MA
55.43TWDUpdated Aug 20, 2026Avg 10-Day Volume
173.54KSharesUpdated Aug 20, 2026Avg 30-Day Volume
203.87KSharesUpdated Aug 20, 2026Diluted EPS (TTM)
3.37TWDUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.15: safe zoneNotable
Altman Z-Score: 4.15
High earnings qualityNotable
Earnings Quality Score: 0.50
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $23.07M, above the global median of $16.24MNotable
Levered free cash flow (USD): 23,067,716.186Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Beijing Leadman Biochemistry Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Hanbon Science & Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Baolingbao Biology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlow
Orthofix Medical Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Beijing Kawin Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Cabaletta Bio Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Ocugen Inc.
Tier 1ProductionApproval-Gated PipelineRule
Anhui Fengyuan Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shaanxi Panlong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Guangdong VTR Bio-Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Zhejiang Xidamen Textile Co. Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Gürsel Turizm Taşımacılık Ve Ticaret A.Ş.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Ipca Laboratories Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities